Dermapharm Holding SE (LON:0A5J)
London flag London · Delayed Price · Currency is GBP · Price in EUR
40.82
+0.22 (0.54%)
At close: Mar 12, 2026

Dermapharm Holding SE Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
1,9011,7321,9781,7924,0382,748
Market Cap Growth
7.41%-12.45%10.40%-55.63%46.97%51.52%
Enterprise Value
2,6452,4862,8272,2114,4463,211
Last Close Price
35.3931.0535.0630.9567.2545.16
PE Ratio
18.7718.4136.5515.0522.9435.73
PS Ratio
1.851.751.981.945.013.79
PB Ratio
3.373.444.183.799.629.45
P/TBV Ratio
---41.96310.95-
P/FCF Ratio
13.2512.8412.828.1025.4233.96
P/OCF Ratio
10.5510.4010.397.0019.2023.39
EV/Sales Ratio
2.612.522.832.405.514.43
EV/EBITDA Ratio
11.5811.9914.798.2416.9523.12
EV/EBIT Ratio
13.2613.5416.878.8217.8925.58
EV/FCF Ratio
18.4418.4318.319.9927.9839.69
Debt / Equity Ratio
1.561.632.010.971.161.87
Debt / EBITDA Ratio
3.843.854.831.691.833.81
Debt / FCF Ratio
6.156.076.152.073.076.72
Net Debt / Equity Ratio
1.341.431.710.680.841.49
Net Debt / EBITDA Ratio
3.363.464.241.201.343.12
Net Debt / FCF Ratio
5.265.325.251.462.215.36
Asset Turnover
0.550.560.640.740.730.71
Inventory Turnover
1.221.341.551.571.561.86
Quick Ratio
0.950.720.751.181.611.39
Current Ratio
2.201.821.602.453.343.01
Return on Equity (ROE)
18.50%19.38%11.24%25.69%50.68%28.21%
Return on Assets (ROA)
6.77%6.55%6.76%12.53%14.06%7.72%
Return on Invested Capital (ROIC)
10.31%9.76%9.29%19.12%24.46%12.55%
Return on Capital Employed (ROCE)
12.60%12.70%10.90%23.70%23.60%12.80%
Earnings Yield
5.33%5.43%2.74%6.64%4.36%2.80%
FCF Yield
7.55%7.79%7.80%12.35%3.93%2.94%
Dividend Yield
2.00%2.40%2.18%3.01%2.71%1.75%
Payout Ratio
41.76%41.64%90.64%87.04%22.61%50.19%
Buyback Yield / Dilution
0.14%-----
Total Shareholder Return
2.14%2.40%2.18%3.01%2.71%1.75%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.